Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.30542 | 11 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.30509 | 12 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.31218 | 12 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.24736 | 12 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.25655 | 12 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.36933 | 13 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.34585 | 13 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.49254 | 22 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.31784 | 14 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.3019 | 13 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.29783 | 12 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.27197 | 12 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.29545 | 12 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.29522 | 12 |